Vitetta L, Briskey D, Alford H, Hall S, Coulson S
rotate injection sites with each dose
Who BPC-157 Is For You may be a fit for BPC-157 therapy if: The patients we see most often are professionals in their 40s and 50s who lift, run, cycle, or play recreational sports, and who can no longer push through injuries the way they did in their 20s and 30s
[15] Animal studies in vivo An in vivo study in aging mice found that epitalon treatment significantly reduced the incidence of chromosomal aberrations, both for wild-type mice and for mice characterized by an accelerated aging phenotype, which is consistent with increases in telomere length
Always refer to the manufacturer's instructions and consult your healthcare provider if you have any doubts about your specific product